Krsnaa Diagnostics Limited (BOM:543328)
India · Delayed Price · Currency is INR 667.40
-8.10 (-1.20%)
At close: Feb 13, 2026
Krsnaa Diagnostics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 7,662 | 7,172 | 6,196 | 4,871 | 4,555 | 3,965 |
Revenue Growth (YoY) | 9.88% | 15.74% | 27.20% | 6.95% | 14.88% | 53.41% |
Cost of Revenue | 1,796 | 1,727 | 1,513 | 899.54 | 755.7 | 949.21 |
Gross Profit | 5,866 | 5,445 | 4,683 | 3,972 | 3,799 | 3,015 |
Selling, General & Admin | 2,119 | 2,046 | 1,888 | 1,680 | 1,724 | 1,464 |
Other Operating Expenses | 1,648 | 1,498 | 1,353 | 1,062 | 757.77 | 607.91 |
Operating Expenses | 4,665 | 4,427 | 3,987 | 3,279 | 2,895 | 2,447 |
Operating Income | 1,201 | 1,018 | 696.44 | 692.39 | 903.37 | 568.78 |
Interest Expense | -262 | -217.58 | -140.87 | -64.35 | -168.63 | -249.27 |
Interest & Investment Income | 167 | 167 | 167.6 | 181.24 | 149.09 | 122.25 |
Other Non Operating Income (Expenses) | -79.6 | 12.96 | -23.67 | -9.03 | -16.27 | -10.02 |
EBT Excluding Unusual Items | 1,026 | 980.03 | 699.5 | 800.25 | 867.56 | 431.74 |
Gain (Loss) on Sale of Assets | 46.84 | 46.84 | 0.57 | 1.76 | -2.48 | -5.06 |
Other Unusual Items | - | - | - | - | - | 2,528 |
Pretax Income | 1,073 | 1,027 | 700.07 | 802.01 | 865.08 | 2,955 |
Income Tax Expense | 268.82 | 250.79 | 131.7 | 180.9 | 181.2 | 1,105 |
Net Income | 803.87 | 776.08 | 568.37 | 621.11 | 683.88 | 1,849 |
Net Income to Common | 803.87 | 776.08 | 568.37 | 621.11 | 683.88 | 1,849 |
Net Income Growth | 6.25% | 36.55% | -8.49% | -9.18% | -63.02% | - |
Shares Outstanding (Basic) | 32 | 32 | 32 | 31 | 30 | 12 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 32 | 30 | 26 |
Shares Change (YoY) | -0.91% | 0.33% | 1.99% | 7.74% | 16.13% | 149.21% |
EPS (Basic) | 24.85 | 24.03 | 17.90 | 19.78 | 22.89 | 160.36 |
EPS (Diluted) | 24.46 | 23.56 | 17.31 | 19.29 | 22.88 | 12.25 |
EPS Growth | 7.23% | 36.11% | -10.26% | -15.69% | 86.72% | - |
Free Cash Flow | - | -393 | -1,695 | -650.59 | -37.95 | 357.18 |
Free Cash Flow Per Share | - | -11.93 | -51.63 | -20.21 | -1.27 | 13.88 |
Dividend Per Share | - | 2.750 | 2.500 | 2.750 | 2.500 | - |
Dividend Growth | - | 10.00% | -9.09% | 10.00% | - | - |
Gross Margin | 76.55% | 75.92% | 75.58% | 81.53% | 83.41% | 76.06% |
Operating Margin | 15.68% | 14.19% | 11.24% | 14.21% | 19.84% | 14.35% |
Profit Margin | 10.49% | 10.82% | 9.17% | 12.75% | 15.02% | 46.65% |
Free Cash Flow Margin | - | -5.48% | -27.36% | -13.36% | -0.83% | 9.01% |
EBITDA | 2,067 | 1,799 | 1,365 | 1,220 | 1,312 | 929.6 |
EBITDA Margin | 26.97% | 25.08% | 22.02% | 25.04% | 28.81% | 23.45% |
D&A For EBITDA | 865.68 | 780.99 | 668.07 | 527.33 | 408.85 | 360.82 |
EBIT | 1,201 | 1,018 | 696.44 | 692.39 | 903.37 | 568.78 |
EBIT Margin | 15.68% | 14.19% | 11.24% | 14.21% | 19.84% | 14.35% |
Effective Tax Rate | 25.06% | 24.42% | 18.81% | 22.56% | 20.95% | 37.41% |
Revenue as Reported | 7,825 | 7,427 | 6,364 | 5,065 | 4,704 | 6,615 |
Advertising Expenses | - | 19.81 | 29.36 | 31.91 | 18.09 | 10.33 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.